To explore the differences in the green channel process of stroke in various regions of the same province, to target and shorten the time delay of emergency process, and to explore the key technologies of endovascular treatment of acute ischemic stroke. To investigate the use and embolectomy effect of Reco, the first embolectomy stent in China, in economically developed areas. Health economic assessment (cost-benefit analysis) of ischemic stroke patients in various regions of the province.
The Reco Embolectomy Stent is indicated for patients who cannot be treated with intravenous tissue activator (IVt-PA) or who have failed IVt-PA therapy and is intended to remove thrombus from a large intracranial vessel in patients with ischemic stroke to restore blood flow.
Study Type
OBSERVATIONAL
Enrollment
300
The First People's Hospital of Changzhou
Changzhou, Jiangsu, China
The time between the onset of the disease and the opening of the blood vessels
Calculate the time from onset to vessel opening
Time frame: Immediately after surgery
Functional independence at 90 days (defined as mRS≤2)
mRS scores were performed 90 days after surgery
Time frame: 90day after surgery
Symptomatic intracranial hemorrhage within 24 hours after surgery
Symptomatic intracranial hemorrhage was evaluated by CT 24 hours after operation
Time frame: 24 hours after surgery
Time from onset to admission
Calculate the time from onset to admission
Time frame: Immediately after surgery
Time from admission and puncture time
Calculate the time from onset to admission
Time frame: Immediately after surgery
Puncture to the time of vessel opening
Calculate the time from puncture to vascular opening
Time frame: Immediately after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.